Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model

Ronald L. Klein, Robert D. Dayton, Karen M. Henderson, Leonard Petrucelli

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

Parkin is a ubiquitin ligase involved in the ubiquitin-proteasome system. Elevating parkin expression in cells reduces markers of oxidative stress while blocking parkin expression increases oxidative stress. In parkin gene knock down mouse and fly models, mitochondria function is deficient. Parkin is neuroprotective against a variety of toxic insults, while it remains unclear which of the above properties of parkin may mediate the protective actions. One of the models for which parkin is protective is overexpression of alpha-synuclein, a protein that self-aggregates in Parkinson disease. The microtubule-associated protein tau is another protein that self-aggregates in specific neurodegenerative diseases that also involve loss of dopamine neurons such as frontotemporal dementia with parkinsonism linked to chromosome 17, progressive supranuclear palsy and corticobasal degeneration. We recently developed a tau-induced dopaminergic degeneration model in rats using adeno-associated virus vectors. In this study, we successfully targeted either a mixed tau/parkin vector or mixed tau/control vector to the rat substantia nigra. While there was significant loss of dopamine neurons in the tau/control group relative to uninjected substantia nigra, there was no cell loss in the tau/parkin group. We found no difference in total tau levels between tau/control and tau/parkin groups. Parkin therefore protects dopamine neurons against tau as it does against alpha-synuclein, which further supports parkin as a therapeutic target for diseases involving loss of dopamine neurons.

Original languageEnglish (US)
Pages (from-to)130-135
Number of pages6
JournalNeuroscience Letters
Volume401
Issue number1-2
DOIs
StatePublished - Jun 19 2006

Fingerprint

Dopaminergic Neurons
Substantia Nigra
alpha-Synuclein
Ubiquitin
Genes
Oxidative Stress
Gene Knockdown Techniques
Progressive Supranuclear Palsy
Frontotemporal Dementia
Dependovirus
Chromosomes, Human, Pair 17
Microtubule-Associated Proteins
Poisons
Proteasome Endopeptidase Complex
Ligases
Diptera
Neurodegenerative Diseases
Parkinson Disease
Mitochondria
Control Groups

Keywords

  • Adeno-associated virus
  • Gene therapy
  • Neurodegenerative disease
  • Parkin
  • Substantia nigra
  • Tau

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model. / Klein, Ronald L.; Dayton, Robert D.; Henderson, Karen M.; Petrucelli, Leonard.

In: Neuroscience Letters, Vol. 401, No. 1-2, 19.06.2006, p. 130-135.

Research output: Contribution to journalArticle

Klein, Ronald L. ; Dayton, Robert D. ; Henderson, Karen M. ; Petrucelli, Leonard. / Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model. In: Neuroscience Letters. 2006 ; Vol. 401, No. 1-2. pp. 130-135.
@article{85b50162f1174ff9b43182eb03fb55c7,
title = "Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model",
abstract = "Parkin is a ubiquitin ligase involved in the ubiquitin-proteasome system. Elevating parkin expression in cells reduces markers of oxidative stress while blocking parkin expression increases oxidative stress. In parkin gene knock down mouse and fly models, mitochondria function is deficient. Parkin is neuroprotective against a variety of toxic insults, while it remains unclear which of the above properties of parkin may mediate the protective actions. One of the models for which parkin is protective is overexpression of alpha-synuclein, a protein that self-aggregates in Parkinson disease. The microtubule-associated protein tau is another protein that self-aggregates in specific neurodegenerative diseases that also involve loss of dopamine neurons such as frontotemporal dementia with parkinsonism linked to chromosome 17, progressive supranuclear palsy and corticobasal degeneration. We recently developed a tau-induced dopaminergic degeneration model in rats using adeno-associated virus vectors. In this study, we successfully targeted either a mixed tau/parkin vector or mixed tau/control vector to the rat substantia nigra. While there was significant loss of dopamine neurons in the tau/control group relative to uninjected substantia nigra, there was no cell loss in the tau/parkin group. We found no difference in total tau levels between tau/control and tau/parkin groups. Parkin therefore protects dopamine neurons against tau as it does against alpha-synuclein, which further supports parkin as a therapeutic target for diseases involving loss of dopamine neurons.",
keywords = "Adeno-associated virus, Gene therapy, Neurodegenerative disease, Parkin, Substantia nigra, Tau",
author = "Klein, {Ronald L.} and Dayton, {Robert D.} and Henderson, {Karen M.} and Leonard Petrucelli",
year = "2006",
month = "6",
day = "19",
doi = "10.1016/j.neulet.2006.03.001",
language = "English (US)",
volume = "401",
pages = "130--135",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Parkin is protective for substantia nigra dopamine neurons in a tau gene transfer neurodegeneration model

AU - Klein, Ronald L.

AU - Dayton, Robert D.

AU - Henderson, Karen M.

AU - Petrucelli, Leonard

PY - 2006/6/19

Y1 - 2006/6/19

N2 - Parkin is a ubiquitin ligase involved in the ubiquitin-proteasome system. Elevating parkin expression in cells reduces markers of oxidative stress while blocking parkin expression increases oxidative stress. In parkin gene knock down mouse and fly models, mitochondria function is deficient. Parkin is neuroprotective against a variety of toxic insults, while it remains unclear which of the above properties of parkin may mediate the protective actions. One of the models for which parkin is protective is overexpression of alpha-synuclein, a protein that self-aggregates in Parkinson disease. The microtubule-associated protein tau is another protein that self-aggregates in specific neurodegenerative diseases that also involve loss of dopamine neurons such as frontotemporal dementia with parkinsonism linked to chromosome 17, progressive supranuclear palsy and corticobasal degeneration. We recently developed a tau-induced dopaminergic degeneration model in rats using adeno-associated virus vectors. In this study, we successfully targeted either a mixed tau/parkin vector or mixed tau/control vector to the rat substantia nigra. While there was significant loss of dopamine neurons in the tau/control group relative to uninjected substantia nigra, there was no cell loss in the tau/parkin group. We found no difference in total tau levels between tau/control and tau/parkin groups. Parkin therefore protects dopamine neurons against tau as it does against alpha-synuclein, which further supports parkin as a therapeutic target for diseases involving loss of dopamine neurons.

AB - Parkin is a ubiquitin ligase involved in the ubiquitin-proteasome system. Elevating parkin expression in cells reduces markers of oxidative stress while blocking parkin expression increases oxidative stress. In parkin gene knock down mouse and fly models, mitochondria function is deficient. Parkin is neuroprotective against a variety of toxic insults, while it remains unclear which of the above properties of parkin may mediate the protective actions. One of the models for which parkin is protective is overexpression of alpha-synuclein, a protein that self-aggregates in Parkinson disease. The microtubule-associated protein tau is another protein that self-aggregates in specific neurodegenerative diseases that also involve loss of dopamine neurons such as frontotemporal dementia with parkinsonism linked to chromosome 17, progressive supranuclear palsy and corticobasal degeneration. We recently developed a tau-induced dopaminergic degeneration model in rats using adeno-associated virus vectors. In this study, we successfully targeted either a mixed tau/parkin vector or mixed tau/control vector to the rat substantia nigra. While there was significant loss of dopamine neurons in the tau/control group relative to uninjected substantia nigra, there was no cell loss in the tau/parkin group. We found no difference in total tau levels between tau/control and tau/parkin groups. Parkin therefore protects dopamine neurons against tau as it does against alpha-synuclein, which further supports parkin as a therapeutic target for diseases involving loss of dopamine neurons.

KW - Adeno-associated virus

KW - Gene therapy

KW - Neurodegenerative disease

KW - Parkin

KW - Substantia nigra

KW - Tau

UR - http://www.scopus.com/inward/record.url?scp=33646408797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646408797&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2006.03.001

DO - 10.1016/j.neulet.2006.03.001

M3 - Article

C2 - 16554120

AN - SCOPUS:33646408797

VL - 401

SP - 130

EP - 135

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 1-2

ER -